DYSNURVO
LIVE

Serial Number

99649987

Owner

Glaxo Group Limited

Attorney

Christopher M. Hanes

Filing Date

Feb 12, 2026

Add to watchlist:

No watchlists yet
View on USPTO

DYSNURVO Trademark

Serial Number: 99649987

DYSNURVO is a trademark filed by Glaxo Group Limited on February 12, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glaxo Group Limited (144 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

February 12, 2026

Registration Date

Not Registered

Published for Opposition

September 1, 2026

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 6, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 6, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 6, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2026 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 4, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 15, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
May 15, 2026 GNSL
SUSPENSION LETTER WRITTEN
May 15, 2026 CNSL
ASSIGNED TO EXAMINER
May 12, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 12, 2026 MAFR
NEW APPLICATION ENTERED
Feb 12, 2026 NWAP